Clotting factor v (acg or proaccelerin) measurement
A national market document for 85220, CY2024 — dated, cited, vintage-stamped, methods attached, forwardable. 12–18 pages; 6–9 figures, set by this market’s shape.
What the data shows
The Brief is a national document for 85220. Its findings page carries one finding per chapter, each opening the chapter that prints its figure and the table behind it — like these, from the United States, CY2024, the market on this page.
- 1Size and growth. The national market for 85220 ran ~3,061 all-Medicare services (estimated), 1,464 observed fee-for-service in CY2024. The market is down 4.9% year over year. 3 billing groups bill it.
- 2Payment. Half the field lists between $35 and $207 per service; the median group lists $35. Submitted charges are provider-set list amounts, not payments.
- 3Geography. TX, NC, NJ and AZ lead the state markets — together 72% of state-market volume.
What the Brief does not contain. Every table in the Brief is printed in it; nothing it rests on is held back. Figures cover Medicare fee-for-service claims; estimated all-Medicare figures are described in the methods.
This market carries the fuller shape — size and growth, what it pays, and where it sits. The chapters are routed from this market's own record when the document is generated. Every Brief also carries cover, findings, how-these-are-built, methods, appendix.
Two specimen briefs are free to read, whole, nothing removed: 99457 — remote monitoring → · 93000 — routine ECG →
← Back to the 85220 market on Nevvi — everything on that page stays free.